Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

When Early CRO Wins Quietly Create Long-Term Study Risk
Discover how overemphasizing early trial milestones can compromise long-term execution. Learn key strategies to build sustainable operational frameworks for lasting study success.
Breaking The Trial Bottleneck: Smarter, Faster Paths To Patients
AI is speeding clinical trials — but silos and complexity persist. Discover how connected systems and automation can enable faster, more adaptive development.
When Should You Rescue Your Clinical Trial From A Bad RTSM?
Stop settling for tech delays that drain your team. Learn how to evaluate a mid-study transition and implement a rescue plan that restores efficiency and control to your clinical operations.
Trends In Clinical Trials In 2025: Navigating A Transformative Landscape
In 2025, it is likely the clinical trial landscape will be shaped by advancements in artificial intelligence (AI), evolving recruitment strategies, and a renewed focus on equitable access.

Protocol Design Choices That Trigger IRB And Regulatory Requirements
8/20/2026

Learn how protocol choices like AI, adaptive designs, and decentralized methods impact IRB review, participant protections, consent, and key regulatory requirements in clinical research.
Clinical Leader Smart Sourcing Solutions Expo: Mural Health Removing Barriers To Trial Participation
10/28/2025

Learn how one platform is transforming the participant journey to deliver a 60% reduction in participant drop-out and 97% engagement rates, improving retention for even the most vulnerable populations worldwide.
How Community Engagement Drives Better Study Outcomes
4/22/2026

Examples of how embedded community sites and local events show how authentic on‑the‑ground involvement translates into deeper patient relationships and measurable study outcomes.
Strategic CMC Considerations For Pre-IND Meetings: Setting The Stage For A Successful TPP
9/1/2025

In biotechnology, the Pre-Investigational New Drug (Pre-IND) stage is a critical juncture. Explore the pivotal role of Chemistry, Manufacturing, and Controls (CMC) in navigating this phase.
Designing More Representative Trials Through Strategic Planning
5/28/2025

Strategic planning for representative clinical trials improves outcomes, regulatory alignment, recruitment efficiency, and commercial value by ensuring study populations mirror real-world patients.

Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle

Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
Deliver Supply Without Friction. Maintain Control At Every Step

Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains.
Recruitment Strategies: A Behind The Scenes Look

Explore a dynamic recruitment strategy being used to address the growing demand for participants in early-stage clinical trials while overcoming regulatory and ethical challenges.
Accelerate Clinical Trial Cycle Times With Citeline Study Feasibility

Citeline Study Feasibility is a platform that combines subject-matter expertise and machine learning to develop predictive insights for feasibility planning. Clinical trial sponsors can use these insights to identify key data drivers and model their impact, build and simulate feasibility scenarios, accelerate timelines, and make better decisions than with statistical methods alone.
Precision Kitting: Every Sample Matters, Every Detail Counts

Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.